Europe Varicose Vein Treatment Market Research Report – Segmented By Treatment Type, Device, End-User and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 2507
Pages: 130

Europe Varicose Vein Treatment Market Size (2024 to 2029)

The size of the European varicose vein treatment market was worth USD 101.41 million in 2023. The European market is further expected to grow at a CAGR of 6.3% from 2024 to 2029 and be worth USD 146.3 Mn by 2029 from USD 107.8 Mn in 2024.

Factors propelling the growth of the European varicose Vein Treatment Market include increased patient compliance and reliability, increased healthcare costs, and rapid aging growth.

The varicose vein treatment market in Europe is mainly due to the emergence of durable and safe technologies to address the enormous burden of varicose veins and increased access to varicose vein medical devices, owing to patient compliance. Furthermore, there is a new trend in the healthcare industry to remove or destroy superficial veins, improving the patient experience. The European Varicose Vein Treatment Market growth in the future is further driven by an increased incidence of varicose veins, an increasing elderly population, advanced varicose vein treatment devices, occupational involvement in increasing the prevalence of varicose veins, and technological advances. Also, increasing levels of awareness and the development of emerging markets have created many opportunities in the European Varicose Vein Treatment Market. Europe Varicose Vein Treatment Market analysis is performed comprehensively in primary and secondary regions to understand growth factors and factors that hinder the market growth.The challenges associated with inconsistent reimbursement scenarios in treatment procedures and the sustainability of key players in this highly competitive marketplace can limit European Market growth.

This research report segmented and sub-segmented the European varicose Vein Treatment Market into the following categories.

Europe Varicose Vein Treatment Market Analysis By Treatment Types

  • Surgical Treatments

    • Vein Ligation and Stripping

    • Phlebectomy
  • Non-Surgical Treatments
    • Laser Therapy
    • Trans-Illuminated Powered Phlebectomy (Trivex)
  • Radiofrequency Ablation
    • Sclerotherapy

Europe Varicose Vein Treatment Market Analysis By Device

  • Ablation devices

    • Radiofrequency Ablation Devices

    • Laser Ablation Devices
  • Venous Closure Products
  • Surgical Products

Europe Varicose Vein Treatment Market Analysis By End-User

  • Surgery Centres

  • Hospitals

    • Specialty Hospitals
    • Multispecialty Hospitals

Europe Varicose Vein Treatment Market Analysis By Country 

  • UK

  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European government's aggressive action and the growing popularity of advanced therapies are supposed to have a positive impact on market growth. As of 2019, the European varicose vein treatment device market is transitioning to non-invasive medical procedures and expensive surgical procedures for vena cava treatment. Europe's Varicose Vein Treatment Market is likely to be the fastest-growing market due to the developing healthcare infrastructure, rise in patient awareness, soaring disposable income, and benefits of early treatments for varicose vein cases in nations like the UK, Germany, France, Spain, Italy, Norway, and others.

KEY MARKET PLAYERS

Some of the Promising Companies leading the Europe Varicose Vein Treatment Market Profiled in the Report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.)

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample